Nausea, Increased amylase, Increased lipase, Diarrhea and Vomiting.
Contraindicated in patients with personal or family history of medullary thyroid carcinoma (MTC) or in patients with multiple endocrine neoplasia syndrome type 2 (MEN-2)Some drugs that may interact with this drug are acarbose, canagliflozin, carbamazepine, ethosuximide, disopyramide, cyclosporine, dapagliflozin.
Hypoglycemia may occur when used in combination with insulin secretagogues (eg, sulfonylureas) or insulin; consider lowering sulfonylurea or insulin dosage when starting dulaglutideInject this medication under the skin as directed by your doctorBefore injecting each dose, clean the injection site with rubbing alcohol. Change the injection site each time to lessen injury under the skin and to avoid developing problems under the skin (lipodystrophy).
Please consult your doctor when taking this medicine if you are pregnant. It is unknown if this drug passes into breast milk. Consult your doctor before breast-feeding.
Manufacture by Eli Lilly Pakistan (Pvt) Ltd.
Only logged in customers who have purchased this product may leave a review.
Related products
-
Trulicity 1.5Mg/0.5Ml 4Inj 4’S
₨23,400.00
Reviews
There are no reviews yet.